Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-23

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approves Ketorolac tromethamine from Leading Pharma, LLC under an Original Application for a generic formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac Tromethamine (generic) (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)